Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Create Stock SIPAutomate your investments in this
Performance
Open
129.80Prev. Close
131.17Volume
2,18,183Total traded value
2.88 CrUpper Circuit
157.40Lower Circuit
104.93Fundamentals
| Market Cap | ₹4,254Cr |
| ROE | 77.47% |
| P/E Ratio(TTM) | -15.93 |
| EPS(TTM) | -8.23 |
| P/B Ratio | 0.00 |
| Dividend Yield | 0.00% |
| Industry P/E | 33.78 |
| Book Value | -10.62 |
| Debt to Equity | -1.21 |
| Face Value | 1 |
Understand Fundamentals
Financials
About Sun Pharma Adv Res
SPARC is a biopharmaceutical firm focused on innovation in therapeutics and delivery, with a strategic emphasis on the medical fields of oncology and immunology. The company's core mission is to build a sustainable business by embedding key environmental, social, and governance parameters into its business growth model. Its dedicated team comprises 316 individuals, with 85% being highly qualified and experienced scientists in diverse fields.;
| Parent Organisation | Sun Pharma Advanced Research Company Limited |
| Managing Director | Mr. Dilip Shanghvi |
| NSE Symbol | SPARC |
Shareholding Pattern
Sep '24
Dec '24
Mar '25
Jun '25
Sep '25
Top Mutual Funds Invested(1)
| FUND NAME | AUM(%) |
|---|---|
| ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth | 0.61% |
Similar Stocks
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| JSW Infrastructure | NA (0.00%) | 36.70 | ||
| Max Financial Services | NA (0.00%) | 294.07 | ||
| Central Depository Services (India) | NA (0.00%) | 71.93 | ||
| Aegis Vopak Terminals | NA (0.00%) | 166.99 |